Enhancing Clinical Trial Outcomes through Effective Data
Integration, Standardization and Compliance
15th February 2022
Dr. Christopher Pettengell is the Chief Medical Officer at Pentavere, a digital health AI company accelerating the discovery of insights buried in hard-to-access clinical text. After completing his MD at Oxford, Chris first travelled to Canada as a Rhodes Scholar to research HIV before returning to the U.K. to train as a surgeon at Imperial College London. Frustrated with the state of health data, Chris discovered Pentavere and was so impressed with the work they were doing that he moved his family to Canada to join the team. At Pentavere, Chris is focused on developing clinical AI solutions to improve the lives of patients.
Day One - 15th February 2022
9:00 AM Accelerating Clinical Trial Workflows with AI – Beyond the Hype, a Real-World Use Case
Join Janssen Scientific Director, Nigel Hughes, Pentavere Chief Medical Officer Dr. Christopher Pettengell for a fireside chat on the challenges surrounding clinical trial data, and how innovative collaborations between pharma and AI companies, such as Janssen’s collaboration with Pentavere, are driving efficiencies so patients can access treatment sooner. This session will address:
• Increasing complexity of clinical trial data is a key factor impacting clinical trial success, and COVID is accelerating these challenges
• Need for clinical trial data management innovation, which is often overlooked in comparison to AI applications for drug discovery
• A leading real-world use case of Janssen & Pentavere’s successful collaboration using AI to accelerate and de-risk clinical trial data management
In Partnership With :
©2024 IQPC. All rights reserved.
